64 results
HIV HAART Medications - Classification by Names and Mechanism - Updated 01/2021
 - NRTIs
 - NNRTIs
HIV HAART Medications ... - Integrase Inhibitors ... #AIDS #HAART #Medications ... Antiretroviral #Therapy #Pharmacology ... Classification #Classes
Antiarrhythmic Medication Table

#Antiarrhythmic #Medications #Table #Classification #Classes #Cardiology #Pharmacology
Antiarrhythmic Medication ... Table #Antiarrhythmic ... #Medications #Table ... Classification #Classes ... #Cardiology #Pharmacology
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #Antidiabetic #Medications ... #SideEffects #Table ... DecisionAid #Orals #DM2 ... Endocrinology #Pharmacology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... SGLT2 inhibitors ... #table #comparison ... endocrinology #dm2
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
Antiplatelet Medications ... - Summary Table ... #Antiplatelet #Medications ... #Summary #Table ... #Pharmacology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
anti-diabetic medications ... kidney), which causes ... glucose in the urine ... #Pharmacology # ... Medications #DM2
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... #pharmacology #dm2 ... #diabetes #medications
Indications for and pharmacological properties of approved SGLT2 inhibitors

Canagliflozin - Dapagliflozin - Empagliflozin - Ertugliflozin

#SGLT2 #Inhibitors
Indications for ... approved SGLT2 inhibitors ... Ertugliflozin #SGLT2 #Inhibitors ... #pharmacology # ... table
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... - Pharmacology ... not definitively cause ... #Pharmacology # ... Summary #DM2 #diabetes
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Summary table of ... Selective factor Xa inhibitors ... anticoagulation #pharmacology ... #medications #doac ... #comparison #table